跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VASICAN TABLET 8 mg - HSA Drug Approval Details
Approvals
/
HSA
/
VASICAN TABLET 8 mg
Approved
THERAPEUTIC
VASICAN TABLET 8 mg
PT. ACTAVIS INDONESIA
🇸🇬 Health Sciences Authority
Approval Date
Apr 18, 1989
Approval ID
ef84d23a209563e3
Company
PT. ACTAVIS INDONESIA
Type
Therapeutic
Approval Details
Approval Id
ef84d23a209563e3
Drug Name
VASICAN TABLET 8 mg
Product Name
VASICAN TABLET 8 mg
Approval Number
SIN02528P
Approval Date
1989-04-18
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
R05CB02
Atc Item Name
bromhexine
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
BROMHEXINE HCl
8 mg
BROMHEXINE HCL
8 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 18, 1989
Approval ID
ef84d23a209563e3
Type
Therapeutic
Back to HSA Approvals